CSL is a biotherapeutics company based in Melbourne, Australia. It collects human plasma and turns it into therapies used to treat immune deficiencies, bleeding disorders and other serious conditions, and it makes recombinant products for similar uses. Through its vaccines business it produces influenza vaccines for public health programmes and other customers. Its customers are mainly hospitals, clinics, health systems and governments in many countries around the world.
The shares are listed on the Australian Securities Exchange in Australia under the code CSL, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #159 of 1816 on the Australian Securities Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Australia yet.
TrendStrong
94/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average38.2%
From 52-week high-11.1%
MomentumStrong
81/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return68.5%
6-month return53.8%
12-month, skipping last month-16.0%
Stability (higher is calmer)Fair
62/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)41.5%
Worst drawdown, 1 year (smaller is calmer)-55.8%
LiquidityStrong
100/100
Trades actively.
See the numbers →
Avg daily value traded214.48M AUD
Zero-volume days0.0%
IncomeWeak
34/100
Dividend is small or irregular.
See the numbers →
Dividend yield2.1%
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Australia when fundamentals data for this market is added. All Australia stocks.
52-wk range 90.00 – 221.76Daily closes, split-adjusted
Signals
50-day average175.38
200-day average141.95
Golden/death cross (60d)Golden, 29 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)3.81
Technical summary
Daily
Bullish
12 bullish · 0 neutral · 4 bearish
Weekly
Strongly bullish
10 bullish · 0 neutral · 2 bearish
Monthly
Bullish
5 bullish · 1 neutral · 2 bearish
Moving averages (daily)
SMA 10
189.9
Bullish
EMA 10
190.8
Bullish
SMA 20
184.9
Bullish
EMA 20
186.0
Bullish
SMA 50
175.4
Bullish
EMA 50
172.8
Bullish
SMA 100
146.4
Bullish
EMA 100
158.6
Bullish
SMA 200
141.9
Bullish
EMA 200
156.5
Bullish
Oscillators (daily)
RSI (14)
76.76
Bearish
MACD (12, 26)
6.33
Bullish
Momentum (12)
9.77
Bullish
Stochastic %K (14)
88.38
Bearish
Williams %R (14)
-11.62
Bearish
CCI (20)
144.9
Bearish
Pivot points (classic, last session)
S3
191.3
S2
192.6
S1
194.4
Pivot
195.7
R1
197.5
R2
198.8
R3
200.6
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
4.05 AUD
Yield on today's price
2.07%
Frequency
Semi-annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
2.2438
1.8098
2.4508
2.0727
2.1746
1.7989
2.0078
1.6215
1.7583
1.4229
1.5897
1.3491
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in AUD. Educational only, not financial advice.
